GB202113610D0 - Novel method - Google Patents

Novel method

Info

Publication number
GB202113610D0
GB202113610D0 GBGB2113610.6A GB202113610A GB202113610D0 GB 202113610 D0 GB202113610 D0 GB 202113610D0 GB 202113610 A GB202113610 A GB 202113610A GB 202113610 D0 GB202113610 D0 GB 202113610D0
Authority
GB
United Kingdom
Prior art keywords
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2113610.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Francis Crick Institute Ltd
Original Assignee
Francis Crick Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francis Crick Institute Ltd filed Critical Francis Crick Institute Ltd
Priority to GBGB2113610.6A priority Critical patent/GB202113610D0/en
Publication of GB202113610D0 publication Critical patent/GB202113610D0/en
Priority to PCT/GB2022/052410 priority patent/WO2023047123A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
GBGB2113610.6A 2021-09-23 2021-09-23 Novel method Ceased GB202113610D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2113610.6A GB202113610D0 (en) 2021-09-23 2021-09-23 Novel method
PCT/GB2022/052410 WO2023047123A1 (en) 2021-09-23 2022-09-23 Method for determining the suitability of an exo1 inhibitor for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2113610.6A GB202113610D0 (en) 2021-09-23 2021-09-23 Novel method

Publications (1)

Publication Number Publication Date
GB202113610D0 true GB202113610D0 (en) 2021-11-10

Family

ID=78399808

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2113610.6A Ceased GB202113610D0 (en) 2021-09-23 2021-09-23 Novel method

Country Status (2)

Country Link
GB (1) GB202113610D0 (en)
WO (1) WO2023047123A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007325900A1 (en) * 2006-10-20 2008-06-05 Dnar, Inc. DNA damage repair inhibitors and methods for treating cancer
US10676791B2 (en) * 2014-07-25 2020-06-09 Inserm(Institut National De La Sante Et De La Recherche Medicale) Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma
EP3353154B3 (en) 2015-09-25 2022-10-19 Ludwig Institute for Cancer Research Ltd 3-hydroxy-7-(sulfonyl)quinazoline-2,4(1h,3h)-dione and 3-hydroxy-pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives and related compounds as flap-endonuclease 1 (fen-1) inhibitors for use in cancer therapy
WO2019067442A1 (en) * 2017-09-26 2019-04-04 Ideaya Biosciences, Inc. DIHYDROTHIENO[3,2-b]PYRIDINE COMPOUNDS

Also Published As

Publication number Publication date
WO2023047123A1 (en) 2023-03-30

Similar Documents

Publication Publication Date Title
GB202007724D0 (en) Novel method
GB202010104D0 (en) Method
GB202006815D0 (en) Method
GB202004944D0 (en) Method
GB202004863D0 (en) Method
GB202015993D0 (en) Method
GB202014709D0 (en) Method
GB202014432D0 (en) Method
GB202011823D0 (en) Method
GB202010922D0 (en) Method
GB202010046D0 (en) Method
GB202007044D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
IL307395A (en) Novel method
GB202114206D0 (en) Novel method
GB202113610D0 (en) Novel method
GB202103325D0 (en) Novel method
GB202103328D0 (en) Novel method
GB202103327D0 (en) Novel method
GB202018476D0 (en) Novel method
GB202114757D0 (en) Method
GB202104130D0 (en) Method
GB202015479D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)